ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.650
+0.030 (0.65%)
Jan 9, 2026, 4:00 PM EST - Market closed
ENDRA Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+545.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $38 → $30 | Strong Buy | Maintains | $38 → $30 | +545.16% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +717.20% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +889.25% | May 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $75 → $50 | Strong Buy | Maintains | $75 → $50 | +975.27% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +300,975.27% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $175,000 → $15,750 | Strong Buy | Reiterates | $175,000 → $15,750 | +338,609.68% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $210,000 → $175,000 | Strong Buy | Maintains | $210,000 → $175,000 | +3,763,340.86% | Apr 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $210,000 | Strong Buy | Initiates | $210,000 | +4,516,029.03% | Jul 15, 2019 |